Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04947865 · ClinicalTrials.gov registry record · NA

Reflex Excitability in Post-stroke Stiff-Knee Gait

A NA study of Stroke and Chronic Stroke, sponsored by MetroHealth Medical Center.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04947865 is a NA study of Stroke and Chronic Stroke that is active but no longer recruiting, run by MetroHealth Medical Center. The registered enrollment target is 60 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04947865, a NA study of Stroke and Chronic Stroke, is active but no longer recruiting, sponsored by MetroHealth Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the reflex excitability of the rectus femoris in individuals with and without post-stroke Stiff-Knee gait. We use electrical stimulation of the peripheral nerve innervating the rectus femoris for a well-controlled reflex stimulus. We are investigating whether reflex excitability of the rectus femoris correlates with gait kinematics.

Interventions

  • OTHER Peripheral nerve stimulation
  • DEVICE Commercial knee brace

Study Locations (1)

Ohio

  • MetroHealth Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-06-11
Est. Completion 2026-06-11
Phase NA

Sponsor

MetroHealth Medical Center

76 total trials

What the Registry Record Tells You About NCT04947865

The ClinicalTrials.gov registry entry for NCT04947865 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Peripheral nerve stimulation is the first listed.

NCT04947865 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04947865 about?

NCT04947865 is a clinical study titled "Reflex Excitability in Post-stroke Stiff-Knee Gait". The purpose of this study is to examine the reflex excitability of the rectus femoris in individuals with and without post-stroke Stiff-Knee gait. We use electrical stimulation of the peripheral nerve innervating the rectus femoris for a well-controlled reflex stimulus. We are investigating whether ...

What is the current status of trial NCT04947865?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-06-11. Estimated completion is 2026-06-11.

What conditions does trial NCT04947865 study?

This clinical trial studies the following conditions: Stroke, Chronic Stroke, Walking, Difficulty, Gait Disorders, Neurologic, Gait, Hemiplegic.

What interventions are being tested in trial NCT04947865?

The interventions under investigation include: Peripheral nerve stimulation (OTHER), Commercial knee brace (DEVICE).

Who is sponsoring clinical trial NCT04947865?

This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04947865 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.